An ameliorating or therapeutic agent for dyslipidemia which is safe and has high effective and a method of using such an ameliorating or therapeutic agent are provided. The ameliorating or therapeutic agent for dyslipidemia includes at least one selected from the group consisting of EPA and pharmaceutically acceptable salts and esters thereof and nicotinic acid or a pharmaceutically acceptable derivative thereof in combination as active ingredients .
